Milestones
-
Participation in and ultimate acquisition of cardiac catheterization and electrophysiology laboratories CON (January, 2001 through February, 2003)
-
Completion of acquisition of initial endowment (February, 2003)
-
Completion of website and initial descriptive brochure incorporating biographical information of participants committed to the Institute's objectives (March, 2003)
-
Initial published report (Circulation) of a multicenter national initiative in elucidating coronary disease and diabetes (2003)
-
Patent acquisition and initiation of development of a novel quantitative assay of platelet reactivity (2003)
- Development and implementation of the Distinguished Research Alliance between the Cardiovascular Research Institute (CVRI) and Medtronic, Inc. in which robust support for research projects of mutual interest is provided and CVRI and Medtronic scientists interact extensively to develop and test hypotheses pertinent to improved diagnosis and care of patients with heart disease of diverse etiologies (2005)
- Multiple publications in prestigious peer-reviewed journals by CVRI scientists elucidating the nature of increased platelet reactivity in patients with coronary artery disease, molecular biological mechanisms underlying diabetic vasculopathy, pathogenetic factors accelerating cardiomyopathy in diabetes, and the potential of embryonic and bone marrow derived stem cells in the treatment of myocardial infarction (2006)
-
Establishment with 5-year NIH programmatic support of a Regional heart Center (Dr. Martin LeWinter [Principal Investigator] and Dr. Burton Sobel [Co-Principal Investigator]) that will participate in a national consortium in clinical investigation designed to improve the diagnosis and treatment of heart failure of diverse etiologies (2006)
